You have 9 free searches left this month | for more free features.

Antiretroviral therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HIV Transmission in Era of Scaling up Antiretroviral Therapy in

Recruiting
  • HIV-1-infection
  • Antiretroviral Therapy
  • Exposure to antiretroviral therapy
  • Ä€dama, Oromia, Ethiopia
    Public hospitals and health centers in the Adama uptake area
Dec 15, 2022

HIV Infected Individuals in Assiut Governorate, Egypt

Not yet recruiting
  • HIV Infections
    • (no location specified)
    Jul 12, 2023

    Virologically Suppressed People Living With HIV and Factors

    Completed
    • HIV Infections
    • dual therapy
    • Tourcoing, France
      Centre Hospitalier DRON
    Oct 30, 2023

    Analysis of HIV-1 Replication During Antiretroviral Therapy

    Enrolling by invitation
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 13, 2023

      Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)

      Not yet recruiting
      • Refractory HIV Associated Kaposi Sarcoma
      • Dostarlimab in Combination Antiretroviral Therapy
      • (no location specified)
      Dec 2, 2022

      HIV, Antiretroviral Therapy Trial in New York (Heart to Heart)

      Completed
      • HIV
      • Antiretroviral Therapy
      • Heart to Heart
      • New York, New York
        New York University College of Nursing
      Oct 31, 2022

      HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

      Enrolling by invitation
      • HIV
      • Antiretroviral Therapy Interruption(ATI)
      • Washington, District of Columbia
      • +1 more
      Sep 12, 2022

      Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

      Recruiting
      • Human Immunodeficiency Virus
      • +2 more
      • Seattle, Washington
        UW Positve Research, Harborview Medical Center
      May 8, 2023

      HIV-1-infection Trial (Delstrigo, KOCITAF)

      Not yet recruiting
      • HIV-1-infection
      • (no location specified)
      Jun 20, 2023

      Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)

      Not yet recruiting
      • Hiv
      • plasma inflammatory markers
      • CD4/CD8 ratio
      • Nice, France
        CHU Nice
      Jan 16, 2023

      Gut Microbiome After Changes in Antiretroviral Therapy (ART)

      Not yet recruiting
      • HIV Infections
        • (no location specified)
        Oct 20, 2023

        Antiretroviral Adherence and Drug-level Monitoring

        Recruiting
        • HIV Infections
        • +4 more
          • Surabaya, East Java, Indonesia
            Universitas Airlangga Hospital
          Aug 17, 2023

          Chronic HIV Infection Trial in Kisumu (POC VL and targeted DRM testing., SOC VL testing)

          Completed
          • Chronic HIV Infection
          • POC VL and targeted DRM testing.
          • SOC VL testing
          • Kisumu, Kenya
            Rtcp-Faces
          Dec 5, 2022

          HIV-positive People, Treated With Long Acting Antiretroviral

          Active, not recruiting
          • HIV Infections
          • Cabotegravir 600mg/3mL, Rilpivirine 900mg/3mL
          • Milan, Italy
            Ospedale San Raffaele Scientific Institute
          Dec 15, 2022

          HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou

          Recruiting
          • HIV Infection
          • Combined Antiretroviral Therapy
            • Hangzhou, Zhejiang, China
              Zhikai Wan
            Aug 30, 2023

            HIV-1 Infection Trial (ART, DOR/ISL)

            Not yet recruiting
            • HIV-1 Infection
            • (no location specified)
            Jan 4, 2023

            HIV-1-infection Trial in Chapel Hill (MGD014)

            Completed
            • HIV-1-infection
            • MGD014
            • Chapel Hill, North Carolina
              University of North Carolina Chapel Hill
            Aug 31, 2022

            HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

            Not yet recruiting
            • HIV
            • HIV Infections
            • (no location specified)
            Aug 4, 2023

            HIV Infection, Adherence, Medication, Adherence, Treatment Trial in Boston (Next-generation Reader and ID-Cap System, Truvada

            Recruiting
            • HIV Infection
            • +4 more
            • Next-generation Reader and ID-Cap System
            • +2 more
            • Boston, Massachusetts
              Fenway Health
            Dec 20, 2022

            HIV-1-infection, Antenatal Care Trial in Lilongwe (iNSC and Adherence supporter training)

            Completed
            • HIV-1-infection
            • Antenatal Care
            • iNSC and Adherence supporter training
            • Lilongwe, Malawi
              Bwaila District Hospital
            Jan 9, 2023

            HIV Positive Trial in Saint-etienne (blood and urinary samples)

            Not yet recruiting
            • HIV Positive
            • blood and urinary samples
            • Saint-etienne, France
              Chu Saint-Etienne
            Nov 29, 2022

            HIV, Cannabis Use Trial in San Diego (THC Cannabis, CBD Cannabis, Placebo)

            Recruiting
            • HIV
            • Cannabis Use
            • THC Cannabis
            • +2 more
            • San Diego, California
              Ucsd Hnrp-Cmcr
            Aug 23, 2022

            HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

            Recruiting
            • HIV-1-infection
            • B/F/TAF
            • TDF-based triple ART regimen switching to B/F/TAF
            • Shanghai, Shanghai, China
            • +2 more
            Dec 1, 2022

            Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

            Not yet recruiting
            • Multi-Drug Resistant Hiv-1 Infection
            • HIV-1 Infection
            • UB-421
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            HIV-1-infection Trial (TASSO device)

            Not yet recruiting
            • HIV-1-infection
            • TASSO device
            • (no location specified)
            Jun 9, 2022